Sai Life Sciences becomes a signatory of the United Nations Global Compact (UNGC)

Over the past two years, Sai Life Sciences has made significant investments and progress in advancing its Sustainability agenda as part of its organizational transformation initiative, Sai Nxt. Some of the notable highlights: Over the past two years, Sai Life Sciences has made significant investments and progress in advancing its Sustainability agenda as part of its organizational transformation initiative, Sai Nxt. Some of the notable highlights: About Sai Life Sciences Sai Life...

Over the past two years, Sai Life Sciences has made significant investments and progress in advancing its Sustainability agenda as part of its organizational transformation initiative, Sai Nxt. Some of the notable highlights:

About Sai Life Sciences

Sai Life Sciences is a full-service CRO-CDMO that works with innovator pharma and biotech companies globally, to accelerate the discovery, development and commercialisation of complex small molecules. For over two decades, Sai Life Sciences has consistently delivered high-quality, cost-effective solutions to its diverse customers spanning biotechs, small, mid and large pharma. Today, it has over 2200 employees across its facilities in India, UK and USA. Sai Life Sciences is privately held and backed by global investors, TPG Capital and HBM Healthcare Investments. https://www.sailife.com.

Logo: https://mma.prnewswire.com/media/1044186/Sai_Life_Sciences_Logo.jpg